Shanghai Bao Pharmaceuticals Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2019-12-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.baopharma.com
Clinical Trials
5
Active:1
Completed:2
Trial Phases
3 Phases
Phase 1:2
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (40.0%)Phase 2
2 (40.0%)Phase 3
1 (20.0%)A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Gastric/Gastroesophageal Junction CancerBreast CancerColorectal CancerNon-small Cell Lung Cancer (NSCLC)Bile Duct CancerHead and Neck Squamous Cell Carcinoma
- Interventions
- Drug: KJ015 Injection (Subcutaneous Injection)
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT07036185
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
Phase 2
Recruiting
- Conditions
- BurnBurn Wounds - Partial Thickness (2nd Degree)
- Interventions
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT07025408
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Clinical Trial With KJ103 in Anti-GBM Disease
Phase 2
Active, not recruiting
- Conditions
- Anti-Glomerular Basement Membrane Disease
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06607016
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Hyaluronidase Assisted Subcutaneous Infusion
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT06604546
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Su Zhou, Jiangsu, China
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05274659
- Locations
- 🇳🇿
New Zealand Clinical Research, Auckland, New Zealand
News
No news found